Article
A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime…
International Journal of Chronic Obstructive Pulmonary Disease · 2019 · Lehmann S, Ringbæk T, Løkke A, Grote L, Hedner J, Lindberg E
Key facts
| Title | A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study |
|---|---|
| First author | Lehmann S, Ringbæk T, Løkke A, Grote L, Hedner J, Lindberg E |
| Journal | International Journal of Chronic Obstructive Pulmonary Disease |
| Published | Jan 9, 2019 |
| DOI | 10.2147/COPD.S184127 |
| Product codes mentioned | MNR, DQA |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1